- Details
- Description
Packaging Size:
30 capsules
Strength:
40 mg
Composition:
Selpercatinib
Treatment:
Anti-Cancer / Oncology
Form:
Capsule
Brand:
Selpacta 40
Quantity Unit:
Capsules
Manufacturer:
Ziska Pharmaceuticals Limited
Selpacta 40 (Selpercatinib) is an oral targeted anti-cancer medicine containing selpercatinib, a selective RET kinase inhibitor that blocks abnormal RET signaling involved in cancer growth and progression. It is used for the treatment of certain RET fusion-positive or RET mutation-positive cancers, including specific cases of non-small cell lung cancer, thyroid cancer, and other advanced solid tumors. Selpacta 40 contains 40 mg of selpercatinib and is supplied in a 30-capsule pack.
